Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,595 | 3,414 | 4,204 | 5,106 | 2,913 |
| Other current assets | 0 | 78 | 78 | 78 | 78 |
| TOTAL | $2,668 | $3,589 | $4,309 | $5,235 | $3,095 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,668 | $3,589 | $4,309 | $5,235 | $3,095 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 131 | 247 | 157 | 221 | 367 |
| Other current liabilities | 290 | 216 | 157 | 91 | 36 |
| TOTAL | $422 | $463 | $314 | $312 | $403 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $422 | $463 | $314 | $312 | $403 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,249 | 2,249 | 2,249 | 2,249 | 2,249 |
| Retained earnings | -50,464 | -49,453 | -48,482 | -47,450 | -46,431 |
| TOTAL | $2,246 | $3,126 | $3,995 | $4,923 | $2,693 |
| Total Liabilities And Equity | $2,668 | $3,589 | $4,309 | $5,235 | $3,095 |